Hosni assumed his current role in 2021. Jamjoom Pharma has manufacturing facilities in Saudi Arabia and Egypt as well as sales operations in key markets such as the U.A.E., Bahrain, Kuwait, Oman, Iraq, Egypt, Morocco, and Algeria with a workforce of 1,300 people. The company recorded revenues of $102.8 million and net profits of $27.4 million in Q1 2024. Hosni was previously the regional president for Africa and the Middle East at Pfizer, and the commercial director for Egypt and Sudan at GSK.